Objectives: It has been demonstrated that the efficiency of lethal photosensitization can be improved by covalently binding photosensitizing agents to bacteriophage. In this study we have investigated whether a bacteriophage requires the capacity to infect the bacterium to enhance lethal photosensitization when linked to a photosensitizer.
Introduction
Light-activated antimicrobial agents ( photosensitizers) are an appealing alternative to conventional antibiotics for the treatment of localized bacterial infections. Lethal photosensitization (LP) has been demonstrated to be effective at killing a range of bacteria including opportunistic pathogens, commensal cutaneous species, 1 periodontal pathogens 2 and epidemic methicillin-resistant Staphylococcus aureus (EMRSA). 3 LP has two main advantages over conventional antimicrobial chemotherapy. First, the bactericidal effect is limited to the area that is treated with both the photosensitizer and light, preventing disturbance of the wider commensal microbial community. 4 Second, the non-specific mode of action of liberated singlet oxygen ( 1 O 2 ) against bacteria is unlikely to induce the development of protective mechanisms and the subsequent proliferation of these genes through the wider microbial community.
The inherent reactivity of 1 O 2 limits its ability to diffuse through an aqueous environment. The lifetime of 1 O 2 in pure water is $4 ms, which results in a theoretical diffusion distance of 125 nm, if one assumes that the moiety does not interact with a biological molecule. 5 This short-range action (on the scale of biological systems) may possibly limit the effectiveness of LP. We have previously developed methodologies to facilitate the close association of photosensitizer and bacteria using targeting systems based upon the covalent conjugation of the photosensitizer tin (IV) chlorin e6 (SnCe6) onto immunoglobulin G (IgG). 3, 6 More recently, we have found that covalently linking SnCe6 to S. aureus bacteriophage 75, commonly used for typing, targets LP to a range of strains of S. aureus including MRSA. 7 In the study reported herein, we examined whether another unrelated S. aureus bacteriophage, phage F11, a generalized transducing phage, could replace phage 75 in targeting LP to S. aureus strains.
Materials and methods

Bacteria and bacteriophage
The two strains of S. aureus used in these experiments were EMRSA-16 (NCTC 13143), one of the dominant nosocomial MRSA isolates in UK hospitals, and 8325-4, a prophage-free derivative of NCTC 8325 that is methicillin-susceptible. These strains were grown on Columbia agar (Oxoid Ltd, Basingstoke, UK) supplemented with 5% (v/v) defibrinated horse blood (CBA). Escherichia coli 10418 was also incorporated as a Gram-negative control. In preparation for the LP experiments, a colony was inoculated into 20 mL of nutrient broth no. 2 (NB2) containing 10 mM CaCl 2 and grown aerobically for 16 h at 378C in a shaking incubator. The cultures were then washed by centrifugation and re-suspension in PBS containing 10 mM CaCl 2 and adjusted to a final optical density at 600 nm (OD 600 ) of 0.05; these cell suspensions contained $1Â10 7 cfu/mL. Bacteriophage F11 is a generalized transducing phage present in S. aureus NCTC 8325 as a prophage. 8 This bacteriophage can infect the NCTC 8325 derivative 8325-4, but not EMRSA-16. Phage F11 was propagated in S. aureus 8325-4 using the phage overlay method and SnCe6 was covalently conjugated to the bacteriophage using methods described previously. 7 The concentration of SnCe6 bound to the phage was determined by spectral analysis against a calibration curve generated from known concentrations of SnCe6. In different experiments, between 7.5Â10 6 and 4.7Â10 7 pfu of bacteriophage was used in conjugation reactions and the amount of SnCe6 bound varied between 3.5 and 7 mg/mL.
LP experiments
Fifty microlitres of the SnCe6/F11 conjugate was added to 50 mL of bacterial suspension in a sterile 96-well plate. The controls consisted of: SnCe6 alone (at the same concentration as the conjugate); F11 alone (at the same titre as the conjugate); and PBS. All of the mixtures were incubated in the dark, with stirring, for 30 min prior to exposure to laser light. The relevant samples were then sequentially exposed to laser light (632.8 nm) from a helium/ neon (HeNe) gas laser with a measured power output of 29.2 mW (Spectra-Physics, Darmstadt-Kranichstein, Germany) for a period of 5 min; the mixtures were magnetically stirred throughout the course of an experiment. Additional 'dark controls' were also conducted for these four variables without laser light. The number of viable bacteria remaining in the samples was determined immediately following exposure to the laser light by serial dilution and enumeration of cfu on CBA. Each experimental variable was repeated as a duplicate.
The duplicate experiments with both strains of S. aureus were conducted a total of four times (n¼ 8), whilst those for E. coli were repeated twice (n¼ 4). The null hypothesis was that there was no difference between the log 10 counts of the number of cfu using various different experimental parameters; this was analysed by Student's t-test to yield P values.
Results
When compared with the control, which was not exposed to laser light or to photosensitizer, the SnCe6/F11 conjugate in the presence of laser light yielded a 2.31 log 10 reduction (P, 0.05) in the number of viable bacteria recovered from the culture of S. aureus 8325-4 and a 2.63 log 10 reduction (P,0.05) for the culture of EMRSA-16. In the presence of laser light, the SnCe6/ F11 conjugate did not result in significant killing of E. coli 10418. None of the other combinations of controls (i.e. SnCe6 only, phage only and 'dark controls') produced significant bacterial kills (Figure 1 ). 
Discussion
We have previously shown that bacteriophage 75, a serotype F staphylococcal phage, could be used to target LP to a range of S. aureus strains including strains it could not infect. The capacity of bacteriophage 75 to target LP to a range of S. aureus strains was surprising since this phage has a restricted host range. The question we asked in the current study was whether other staphylophage could target LP to a range of S. aureus strains, once conjugated to a photosensitizer, or if this was a specific trait of phage 75. We did this by investigating the capacity of bacteriophage F11, a prototypic group B-transducing phage, 9 to target LP to S. aureus.
When SnCe6 was conjugated to S. aureus bacteriophage F11, for S. aureus strains 8325-4 and EMRSA-16 in the presence of laser light there was an increase in the killing of these bacteria by 2.39 log 10 and 2.35 log 10 , respectively, when compared with the equivalent concentration of SnCe6 alone (i.e. free SnCe6 that was not conjugated to the bacteriophage). Since it is known that staphylophage have the capacity to bind to all strains of S. aureus 10 and bacteriophage F11 is not capable of infecting strain EMRSA-16, the kill achieved by the SnCe6/F11 conjugate suggests that the photosensitizer/bacteriophage conjugate only needs to bind to the bacterial cell to induce killing in the presence of laser light. The selectivity of the photosensitizer/bacteriophage conjugate in targeting LP to S. aureus was demonstrated by the inability to cause significant killing of E. coli in the presence of laser light.
Our results demonstrate that it is possible to use different serotypes of staphylophage as vehicles to deliver photosensitizer payloads to the surface of S. aureus thus enabling selective LP of this bacterium in the presence of laser light. Such designer composites would not only possess all of the advantages that photodynamic therapy has over conventional antibiotic therapy, as described in the introduction, but they would also ensure there was minimal collateral damage to the host and its indigenous microflora.
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